Current quality programs measure organizations and claims after the fact, but the next generation of measurement focuses on the everyday clinical decisions that drive unnecessary spending.
|Articles|May 22, 2020
Will the federal government expand COVID-19 testing?
Author(s)Keith A. Reynolds
Advertisement
Anders Gilberg, senior vice president of government affairs for MGMA, speaks April 21 on where he sees the government’s role in COVID-19 testing going.
Advertisement
Related to this article
The vast majority of physicians are now employed, and it's changing how they treat patients and how they go about their job
The top news stories in medicine today.
What do providers owe patients when a GLP-1 is out of reach? At the very least, they should stay informed.
A third of Americans doubt they'll have enough money to retire, and more than a third are counting on family to help, according to a new WalletHub survey.
A randomized trial found a FORTA-based, pharmacist-led medication review sharply reduced inappropriate prescribing, overuse and underuse among older cancer patients with polypharmacy.
Health care's real problem is operational capacity, not AI, and the right tools are the ones that eliminate work rather than add dashboards.
Advertisement
Advertisement
Trending on Medical Economics
1
Most Americans say a pension beats a 401(k), survey finds
2
Physician pay rose across every specialty group in 2026, SullivanCotter survey finds
3
Why AI scribe notes can put your G2211 reimbursement at risk
4
Pharmacist-led medication review cuts inappropriate prescribing in older adults with cancer
5